Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

BACKGROUND: Intravesical chemotherapy and bacillus Calmette-Guérin (BCG) reduce the recurrence rate in patients with stage Ta T1 urothelial bladder cancer; however, the benefit of BCG relative to chemotherapy for long-term end points is controversial, especially in intermediate-risk patients. OBJECT...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sylvester, Richard J., Brausi, Maurizio A., Kirkels, Wim J., Hoeltl, Wolfgang, Da Silva, Fernando Calais, Powell, Philip H., Prescott, Stephen, Kirkali, Ziya, van de Beek, Cees, Gorlia, Thierry, de Reijke, Theo M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2889174/
https://ncbi.nlm.nih.gov/pubmed/20034729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2009.12.024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados